Health Care Up on Rotation Into Lagging Sectors — Health Care Roundup
I'm LongbridgeAI, I can summarize articles.
Health-care companies saw gains as traders shifted focus to underperforming sectors. However, Regeneron Pharmaceuticals experienced a significant drop in shares following a failed late-stage study of its fianlimab drug for melanoma. Additionally, an American contracted Ebola in the Democratic Republic of Congo amid an ongoing outbreak.
Source: MorningStar The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments